IL1B and adenocarcinoma: Histopathologic analysis of lungs from anti–IL-1β–treated mice revealed that the percentages of lung area occupied by tumor and adenoma and adenocarcinoma lesions were reduced by 47.5% and 53%, respectively (Supplemental Figure 3, A and B).